ZA200710857B - Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids - Google Patents
Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acidsInfo
- Publication number
- ZA200710857B ZA200710857B ZA200710857A ZA200710857A ZA200710857B ZA 200710857 B ZA200710857 B ZA 200710857B ZA 200710857 A ZA200710857 A ZA 200710857A ZA 200710857 A ZA200710857 A ZA 200710857A ZA 200710857 B ZA200710857 B ZA 200710857B
- Authority
- ZA
- South Africa
- Prior art keywords
- azetidin
- biphenylyl
- processes
- production
- phosphonic acids
- Prior art date
Links
- CWWMGJTVBCJUFK-UHFFFAOYSA-N OP(O)=O.N1C(=O)CC1C1=CC=CC=C1C1=CC=CC=C1 Chemical class OP(O)=O.N1C(=O)CC1C1=CC=CC=C1C1=CC=CC=C1 CWWMGJTVBCJUFK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
- C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68448105P | 2005-05-25 | 2005-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710857B true ZA200710857B (en) | 2008-12-31 |
Family
ID=37103301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710857A ZA200710857B (en) | 2005-05-25 | 2007-12-13 | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090099355A1 (enExample) |
| EP (1) | EP1896135A2 (enExample) |
| JP (1) | JP2008545700A (enExample) |
| KR (1) | KR20080025077A (enExample) |
| CN (1) | CN101222950A (enExample) |
| AU (1) | AU2006249905A1 (enExample) |
| BR (1) | BRPI0611415A2 (enExample) |
| CA (1) | CA2609506A1 (enExample) |
| EA (1) | EA200702614A1 (enExample) |
| IL (1) | IL187626A0 (enExample) |
| MA (1) | MA29553B1 (enExample) |
| NO (1) | NO20076597L (enExample) |
| TW (1) | TW200801027A (enExample) |
| WO (1) | WO2006127893A2 (enExample) |
| ZA (1) | ZA200710857B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| DE602004008100T2 (de) * | 2003-11-10 | 2008-04-30 | Microbia Inc., Cambridge | 4-biarylyl-1-phenylazetidin-2-one |
| WO2005061452A1 (en) | 2003-12-23 | 2005-07-07 | Astrazeneca Ab | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| US20060135755A1 (en) | 2004-12-20 | 2006-06-22 | Schering Corporation | Process for the synthesis of azetidinones |
| UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
| SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| MY148538A (en) | 2005-06-22 | 2013-04-30 | Astrazeneca Ab | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| DE102005055726A1 (de) * | 2005-11-23 | 2007-08-30 | Sanofi-Aventis Deutschland Gmbh | Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| AR060623A1 (es) | 2006-04-27 | 2008-07-02 | Astrazeneca Ab | Compuestos derivados de 2-azetidinona y un metodo de preparacion |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| WO2008061238A2 (en) * | 2006-11-16 | 2008-05-22 | Ironwood Pharmaceuticals, Inc. | Processes for production of 4-biphenylyazetidin-2-ones |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007063671A1 (de) | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| WO2009157019A2 (en) * | 2008-06-23 | 2009-12-30 | Ind-Swift Laboratories Limited | Process for preparing ezetimibe using novel allyl intermediates |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| RU2012111354A (ru) | 2009-08-26 | 2013-10-10 | Санофи | Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| CN102285932B (zh) * | 2011-09-01 | 2013-06-12 | 浙江大学 | 一种依替米贝中间体的制备方法 |
| KR102062343B1 (ko) * | 2011-12-30 | 2020-01-02 | 다우 아그로사이언시즈 엘엘씨 | 4-클로로-2-플루오로-3-치환된-페닐보론산 피나콜 에스테르의 형성 방법 및 그의 사용 방법 |
| CN103396429B (zh) * | 2013-06-28 | 2016-05-25 | 杭州师范大学 | 一种硅手性中心的硅烷衍生物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT67341A (en) * | 1991-07-23 | 1995-03-28 | Schering Corp | Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| CA2158191A1 (en) * | 1994-09-16 | 1996-03-17 | Junji Yokoi | Method for preventing settlement of aquatic fouling organisms |
| ES2244238T3 (es) * | 1998-12-07 | 2005-12-01 | Schering Corporation | Proceso para la sintesis de azetidinonas. |
| US6207822B1 (en) * | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
| IL156552A0 (en) * | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| WO2002050027A1 (de) * | 2000-12-21 | 2002-06-27 | Aventis Pharma Deutschland Gmbh | Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen |
| TWI291957B (en) * | 2001-02-23 | 2008-01-01 | Kotobuki Pharmaceutical Co Ltd | Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same |
| DE60206365T2 (de) * | 2001-03-28 | 2006-07-06 | Schering Corporation, Kenilworth | Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten |
| CN1805926A (zh) * | 2003-05-05 | 2006-07-19 | 兰贝克赛实验室有限公司 | 二苯基氮杂环丁酮衍生物的反式异构体的制备方法 |
| DE602004008100T2 (de) * | 2003-11-10 | 2008-04-30 | Microbia Inc., Cambridge | 4-biarylyl-1-phenylazetidin-2-one |
| US20090005321A1 (en) * | 2005-02-09 | 2009-01-01 | Microbia, Inc. | Phenylazetidinone Derivatives |
| TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
| US20080200669A1 (en) * | 2005-05-11 | 2008-08-21 | Microbia, Inc. | Processes For Production of Phenolic 4-Biphenylylazetidin-2-Ones |
-
2006
- 2006-05-25 JP JP2008513703A patent/JP2008545700A/ja active Pending
- 2006-05-25 US US11/915,241 patent/US20090099355A1/en not_active Abandoned
- 2006-05-25 EP EP06771157A patent/EP1896135A2/en not_active Withdrawn
- 2006-05-25 KR KR1020077029875A patent/KR20080025077A/ko not_active Withdrawn
- 2006-05-25 CN CNA2006800254529A patent/CN101222950A/zh active Pending
- 2006-05-25 EA EA200702614A patent/EA200702614A1/ru unknown
- 2006-05-25 WO PCT/US2006/020226 patent/WO2006127893A2/en not_active Ceased
- 2006-05-25 BR BRPI0611415-6A patent/BRPI0611415A2/pt not_active Application Discontinuation
- 2006-05-25 CA CA002609506A patent/CA2609506A1/en not_active Abandoned
- 2006-05-25 AU AU2006249905A patent/AU2006249905A1/en not_active Abandoned
- 2006-06-23 TW TW095122648A patent/TW200801027A/zh unknown
-
2007
- 2007-11-22 IL IL187626A patent/IL187626A0/en unknown
- 2007-12-13 ZA ZA200710857A patent/ZA200710857B/xx unknown
- 2007-12-20 MA MA30488A patent/MA29553B1/fr unknown
- 2007-12-20 NO NO20076597A patent/NO20076597L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0611415A2 (pt) | 2010-09-08 |
| EA200702614A1 (ru) | 2008-04-28 |
| AU2006249905A1 (en) | 2006-11-30 |
| CN101222950A (zh) | 2008-07-16 |
| WO2006127893A2 (en) | 2006-11-30 |
| WO2006127893A3 (en) | 2007-03-08 |
| NO20076597L (no) | 2008-01-18 |
| KR20080025077A (ko) | 2008-03-19 |
| JP2008545700A (ja) | 2008-12-18 |
| TW200801027A (en) | 2008-01-01 |
| MA29553B1 (fr) | 2008-06-02 |
| CA2609506A1 (en) | 2006-11-30 |
| IL187626A0 (en) | 2008-03-20 |
| EP1896135A2 (en) | 2008-03-12 |
| US20090099355A1 (en) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200710857B (en) | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids | |
| ZA200709028B (en) | Process for the production of acetic acid | |
| TWI371442B (en) | Process for producing carboxylic acid | |
| IL187731A0 (en) | Process for production of bivalirudin | |
| IL185110A0 (en) | Processes for the production of organometallic compounds | |
| ZA200711016B (en) | Method for production of 1-alkyl-3-phenyluracils | |
| EG26797A (en) | Cement production process | |
| ZA200706824B (en) | Process for the production of magnesium oxide | |
| IL183591A0 (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
| EP1861408A4 (en) | PROCESS FOR PRODUCING HYDROCHLOROSILANES | |
| PL1990336T3 (pl) | Sposób wytwarzania związku 5-alkoksy-4-hydroksymetylopirazolowego | |
| IL187155A0 (en) | Process for production of 4-biphenylazetidin-2-ones | |
| IL189101A0 (en) | Novel processes for the production of amorphous rabeprazole sodium | |
| ITBO20060718A1 (it) | Macchina per la produzione di filtri composti | |
| ZA200710066B (en) | Process for production of 4-biphenylylazetidin-2-ones | |
| IL172037A0 (en) | Letrozole production process | |
| GB2432583B (en) | Letrozole production process | |
| EP1947083A4 (en) | PROCESS FOR THE PREPARATION OF ARALKYLOXYPYRROLIDINE DERIVATIVES | |
| PT1829872E (pt) | Processo para produzir um composto indole | |
| IL182134A0 (en) | Process for production of 2-chloro-4-nitroimidazole | |
| HK1113553A (en) | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids | |
| EP1864993A4 (en) | METHOD FOR PRODUCING A GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE | |
| EP1860207A4 (en) | TARGET PROCESS | |
| HU0600517D0 (en) | Process for the production of benzylidene-rosiglitazone base | |
| IL193032A0 (en) | Process for the production of phosphorous compounds |